Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis

被引:73
作者
Gårdsvoll, H [1 ]
Dano, K [1 ]
Ploug, M [1 ]
机构
[1] Rigshosp, Finsen Lab, DK-2100 Copenhagen O, Denmark
关键词
D O I
10.1074/jbc.274.53.37995
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The urokinase-type plasminogen activator receptor (uPAR) is a glycolipid anchored multidomain member of the Ly-6/uPAR protein domain superfamily. Studies by site-directed photoaffinity labeling, chemical cross-linking, and ligand-induced protection against chemical modification have highlighted the possible involvement of uPAR domain I and particularly loop 3 thereof in ligand binding (Ploug, RI. (1998) Biochemistry 37, 16494-16505). Guided by these results we have now performed an alanine scanning analysis of this region in uPAR by site-directed mutagenesis and subsequently measured the effects thereof on the kinetics of uPA binding in real-time by surface plasmon resonance. Only four positions in loop 3 of uPAR domain I exhibited significant changes in the contribution to the free energy of uPA binding (Delta Delta G greater than or equal to 1.3 kcal mol(-1)) upon single-site substitutions to alanine (i.e. Arg(53), Leu(55), Tyr(57), and Leu(66)). The energetic impact of these four alanine substitutions was not caused by gross structural perturbations, since all monoclonal antibodies tested having conformation-dependent epitopes on this domain exhibited unaltered binding kinetics, These sites together with a three-dimensional structure for uPAR may provide an appropriate target for rational drug design aimed at developing new receptor binding antagonists with potential application in cancer therapy.
引用
收藏
页码:37995 / 38003
页数:9
相关论文
共 59 条
[1]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[2]  
2-Z
[3]   Domain interplay in the urokinase receptor - Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains [J].
Behrendt, N ;
Ronne, E ;
Dano, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22885-22894
[4]  
BEHRENDT N, 1991, J BIOL CHEM, V266, P7842
[5]   Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59 [J].
Bodian, DL ;
Davis, SJ ;
Morgan, BP ;
Rushmere, NK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :507-516
[6]   Anatomy of hot spots in protein interfaces [J].
Bogan, AA ;
Thorn, KS .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (01) :1-9
[7]   Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice [J].
Bugge, TH ;
Lund, LR ;
Kombrinck, KK ;
Nielsen, BS ;
Holmbäck, K ;
Drew, AF ;
Flick, MJ ;
Witte, DP ;
Dano, K ;
Degen, JL .
ONCOGENE, 1998, 16 (24) :3097-3104
[8]   Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration [J].
Chapman, HA .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (05) :714-724
[9]   A HOT-SPOT OF BINDING-ENERGY IN A HORMONE-RECEPTOR INTERFACE [J].
CLACKSON, T ;
WELLS, JA .
SCIENCE, 1995, 267 (5196) :383-386
[10]   Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity [J].
Clackson, T ;
Ultsch, MH ;
Wells, JA ;
de Vos, AM .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 277 (05) :1111-1128